Ty Roush is a New York City-based breaking news reporter who frequently covers Russia’s invasion of Ukraine, the automotive industry and sports money. He joined Forbes in 2022 and has covered Exxon acquiring Pioneer for nearly $60 billion, a mysterious respiratory illness affecting dogs across the U.S.
RFK Jr. Calls Report Alleging He Sexually Assaulted His Children’s Nanny—And Ate A Dog—A 'Lot Of Garbage'
Biden Vs.
Semaglutide is associated with a four times higher risk of NAION when used for treating Type 2 diabetes and a seven times higher risk when used for obesity, according to the study. Among the 710 patients with Type 2 diabetes, the rate of developing NAION was 8.9% for those taking semaglutide, compared to 1.8% for patients taking other medications.
Patients who were prescribed semaglutide for weight loss treatment developed NAION at a rate of 6.7%, while patients taking other medications had a rate of 0.8%.We’re launching text message alerts so you'll always know the biggest stories shaping the day’s headlines.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Maker of Ozempic, Wegovy to build massive facility in North CarolinaRooted in fact-based, transparent reporting, Newsy is an award-winning opinion-free network owned by the E.W. Scripps Company that is relentlessly focused on “the why” of every story and seeks to enable a more intimate and immersive understanding of the issues that matter.
Read more »
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, OzempicThe new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy, Ozempic and other drugs.
Read more »
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, OzempicThe new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy, Ozempic and other drugs.
Read more »
Ozempic and Wegovy may reduce inflammation by targeting the brainWeight-loss injections such as Wegovy reduce inflammation in the body by acting on brain cells, according to a study in mice
Read more »
Fake Wegovy and Ozempic warnings: What to knowWHO and Eli Lilly has warned consumers to be cautious of counterfeit versions of popular weight-loss and diabetes drugs like Wegovy, Ozempic being sold online.
Read more »
Bernie Sanders: Ozempic, Wegovy drugmaker is 'ripping off' U.S. over weight loss drug costBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »